LSC
IBB icon

Logan Stone Capital’s iShares Biotechnology ETF IBB Stock Holding History

Logan Stone Capital’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,892
Closed -$706K – 161
2025
Q3 		$706K Buy
+4,892
New +$668K 0.32% 42
2024
Q4 		– Sell
-1,592
Closed -$232K – 130
2024
Q3 		$232K Buy
+1,592
New +$230K 0.06% 120
2022
Q1 		– Sell
-3,556
Closed -$543K – 144
2021
Q4 		$543K Buy
+3,556
New +$551K 0.54% 51

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Logan Stone Capital's IBB Position: Q4 2025 in Review

Logan Stone Capital sold out of iShares Biotechnology ETF (IBB) in Q4 2025, closing a stake of 4,892 shares — an estimated $706K sold.

Logan Stone Capital first reported a position in IBB in Q4 2021 and held it in 3 quarters. The position peaked at $706K in Q3 2025. 958 funds tracked by Wall St. Rank hold IBB as of Q4 2025.

  • Logan Stone Capital reported no remaining iShares Biotechnology ETF position as of Q4 2025 after selling out during the quarter.
  • Logan Stone Capital sold 4,892 iShares Biotechnology ETF shares in Q4 2025, an estimated $706K.
  • Logan Stone Capital first reported a position in iShares Biotechnology ETF in Q4 2021 and held it in 3 quarters.
  • Logan Stone Capital's iShares Biotechnology ETF position peaked at $706K in Q3 2025.
  • 958 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2025.

Based on Logan Stone Capital's 13F filing for Q4 2025, filed 17 Feb 2026.